Blue Heron Biotechnology, Inc., headquartered in the United States, is a leading player in the biotechnology industry, specialising in custom DNA synthesis and gene assembly services. Founded in 2000, the company has established itself as a trusted partner for researchers and organisations in various sectors, including pharmaceuticals, agriculture, and synthetic biology. With a commitment to innovation, Blue Heron offers unique products such as high-fidelity DNA constructs and advanced gene editing tools, setting them apart in a competitive market. Their state-of-the-art technology and expertise have garnered recognition, positioning them as a preferred choice for clients seeking precision and reliability in genetic research. As a pioneer in the field, Blue Heron Biotechnology continues to drive advancements that support scientific discovery and development.
How does Blue Heron Biotechnology, Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the Research Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Blue Heron Biotechnology, Inc.'s score of 23 is lower than 63% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Blue Heron Biotechnology, Inc., headquartered in the US, currently does not have any publicly available carbon emissions data for the most recent year, nor does it report specific reduction targets or initiatives. The company is identified as a current subsidiary, and any potential emissions data or climate commitments may be cascaded from its parent organisation. However, no specific details regarding such data or commitments have been provided. As of now, Blue Heron Biotechnology, Inc. has not outlined any significant climate pledges or reduction initiatives, which may indicate a need for further development in their sustainability strategy. The absence of emissions data and reduction targets suggests that the company may be in the early stages of establishing its climate commitments within the biotechnology sector.
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Blue Heron Biotechnology, Inc. is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.